http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101493543-B1

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
filingDate 2008-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-101493543-B1
titleOfInvention Treatment of imatinib resistant leukemia with 4-aminoquinoline-3-carbonitrile
abstract The present invention provides 4-aminoquinoline-3-carbonitrile compounds useful for treating subjects with BcrAbl positive leukemia resistant to imatinib.
priorityDate 2007-06-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005101780-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID17956383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424370647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415792738
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5330093
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426076831
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457042278
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312145
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3062316
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426076001
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457834382
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID159563025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476917
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93177
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546810
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12428401
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5328941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6505803
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419492476
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450845421
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5291
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966290
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394669
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466556080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID429291404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123596
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454269980

Total number of triples: 47.